.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Julphar
Chinese Patent Office
Accenture
Cipla
Healthtrust
Merck
Baxter
Cantor Fitzgerald
Novartis

Generated: July 27, 2017

DrugPatentWatch Database Preview

LOTENSIN HCT Drug Profile

« Back to Dashboard

What is the patent landscape for Lotensin Hct, and what generic Lotensin Hct alternatives are available?

Lotensin Hct is a drug marketed by Us Pharms Holdings I and is included in one NDA.

The generic ingredient in LOTENSIN HCT is benazepril hydrochloride; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the benazepril hydrochloride; hydrochlorothiazide profile page.

Summary for Tradename: LOTENSIN HCT

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list77
Clinical Trials: see list239
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LOTENSIN HCT at DailyMed

Pharmacology for Tradename: LOTENSIN HCT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-001May 19, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-003May 19, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-002May 19, 1992ABRXYesNo► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-004May 19, 1992ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LOTENSIN HCT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-001May 19, 1992► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-004May 19, 1992► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-003May 19, 1992► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-002May 19, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Citi
Dow
Baxter
Express Scripts
US Army
Johnson and Johnson
Novartis
Merck
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot